According to the Salk Institute site, Virus like particles are supra molecular assemblages incorporating key immunologic features of viruses which include repetitive surfaces, particulate structures with potential for induction of innate immunity through activation of pathogen associated molecular pattern recognition receptors. They carry no replicative genetic information and can be produced in heterologous expression systems at large scale. VLPs thus represent a safe and effective vaccine platform with potential to induce potent B and T cell responses. In addition to being effective vaccines against the corresponding viruses from which they are derived, virus like particles can also be used to present foreign epitopes to the immune system. This can be achieved by genetic fusion or chemical conjugation. This technological innovation has greatly broadened the scope of their use, from immunizing against microbial pathogens to immunotherapy for chronic diseases. Towards this end, VLP have been ...

RTS,S is the leading malaria vaccine in development, but has demonstrated only moderate protective efficacy in clinical trials. RTS,S is a virus-like particle (VLP) that uses the human hepatitis B virus as scaffold to display the malaria sporozoite antigen, circumsporozoite protein (CSP). Particle formation requires four-fold excess scaffold antigen, and as a result, CSP represents only a small portion of the final vaccine construct. Alternative VLP or nanoparticle platforms that reduce the amount of scaffold antigen and increase the amount of the target CSP antigen present in particles may enhance vaccine immunogenicity and efficacy. Here, we describe the production and characterization of a novel VLP that uses the small surface antigen (dS) of duck hepatitis B virus to display CSP. The CSP-dS fusion protein successfully formed VLPs without the need for excess scaffold antigen, and thus CSP represented a larger portion of the vaccine construct. CSP-dS formed large particles approximately 31-74 ...

Creative Biostructure, a US biopharmaceutical company and leader in the supplying of structural biology related products and services, is proud to announce a bunch of new virus like particles products. Besides, the company adds web search function on the site, enabling customers find the products in need with greater ease.. Virus-like particle (VLP) has evolved to become a widely accepted technology, especially in the field of vaccinology. In fact, some VLP-based vaccines are currently used as commercial medical products, and other VLP-based products are at different stages of clinical study.. Creative Biostructure provides virus-like particles containing high concentrations of specific membrane proteins in their native conformation. VLPs in Creative Biostructure are produced with specified membrane proteins on a custom basis, or are available from a selected catalog of Ready VLPs. Sample kits are also available for purchase for preliminary application testing.. Upon the launch of web search ...

Creative Biostructure, a US biopharmaceutical company and leader in the supplying of structural biology related products and services, is proud to announce a bunch of new virus like particles products. Besides, the company adds web search function on the site, enabling customers find the products in need with greater ease.. Virus-like particle (VLP) has evolved to become a widely accepted technology, especially in the field of vaccinology. In fact, some VLP-based vaccines are currently used as commercial medical products, and other VLP-based products are at different stages of clinical study.. Creative Biostructure provides virus-like particles containing high concentrations of specific membrane proteins in their native conformation. VLPs in Creative Biostructure are produced with specified membrane proteins on a custom basis, or are available from a selected catalog of Ready VLPs. Sample kits are also available for purchase for preliminary application testing.. Upon the launch of web search ...

Purpose of reviewThe importance of IgG Fc-effector functions for the efficacy of HIV vaccines is increasingly recognized. Although different types of vaccines were shown to induce antibodies with different Fc-activities, there is no clear strategy how to raise antibody responses with a desired patte

Diane M. Harper, Eduardo L. Franco, Cosette Wheeler, Daron Gale Ferris, David Jenkins, Anne Schuind, Toufik Zahaf, Bruce Innis, Paulo Naud, Newton S. De Carvalho, Cecilia M. Roteli-Martins, Julio Teixeira, Mark M. Blatter, Abner P. Korn, Wim Quint, Gary Dubin ...

Duck hepatitis A virus (DHAV), a non-enveloped ssRNA virus, can cause a highly contagious disease in young ducklings. The three capsid proteins of VP0, VP1 and VP3 are translated within a single large open reading frame (ORF) and hydrolyzed by protease 3CD. However, little is known on whether the recombinant viral structural proteins (VPs) expressed in insect cells could spontaneously assemble into virus-like particles (VLPs) and whether these VLPs could induce protective immunity in young ducklings. To address these issues, the structural polyprotein precursor gene P1 and the protease gene 3CD were amplified by PCR, and the recombinant proteins were expressed in insect cells using a baculovirus expression system for the characterization of their structures and immunogenicity ...

Objective - Influenza VLP • Complex structure • Different protein components • Host cell derived lipid membrane • ESAT6 epitope of M.

Merck & Co. and vaccine delivery specialist Vaxxas started a research collaboration focused on evaluating use of the latters transdermal Nanpatch™ vaccine delivery system with a Merck vaccine candidate.

The base study V503-002 was a 12-month study that is collecting safety and immunogenicity information for six months following the subjects third dose of study vaccine.. An optional extension study (V503-002 EXT1) will collect safety and immunogenicity information through Month 36. Participants enrolled in the 16- to 26-year-old cohort in the base study will not be included in EXT1.. An optional second extension study (V503-002 EXT2) will collect long-term safety and immunogenicity information through approximately 10 years. No study vaccine will be administered in the extension studies. Participants enrolled in the 16- to 26-year-old cohort in the base study will not be included in EXT2. ...

Free of obvious health problems or chronic illnesses (i.e., recent exacerbation or acute episode of chronic illness in the last 3 months) as established by medical history, review of systems, and clinical examination before entering the study. This includes any mental condition that would interfere with subject self-assessment. Subjects with a pre-existing chronic disease will be allowed to participate if the disease is stable. Stable disease is defined as no new onset of exacerbation of pre-existing chronic disease 3 months prior to study vaccine injection ...

Papillomaviruses (PVs) infect epithelial cells and are the main causative agent of cervical carcinoma. There are today more than a hundred different PV types and these can be divided into high risk and low risk types. They infect differentiating epithelial cells which make it cumbersome to propagate and produce human papillomavirus (HPV) virions. A common method to study HPV infection is to use HPV virus like particles (VLPs) produced in recombinant eukaryotic expression systems. Glycosaminoglycans (GAGs) have been described as an initial attachment receptor for several viruses. Our aim was to study the interactions between HPV VLPs and different GAGs to determine how these could affect binding and internalization. We found that soluble heparin was the best GAG inhibitor of HPV-16 VLP binding followed by heparan sulfate of mucosal origin. We could also see that CHO cells deficient in GAG expression had a reduced ability to bind VLPs, as did cells pretreated with heparinase III. Our results ...

Virus-like particles (VLPs) make excellent vaccines. They are non-infectious, often easy to produce in bacterial expression systems, and highly immunogenic. The latter feature is granted by the regularity of the capsid structure, which presents viral (or other) epitopes as dense, highly repetitive arrays that strongly stimulate B cells. VLPs can be used as the basis for vaccines targeting the virus from which they were derived, or they can be used as platforms to display practically any short peptide epitope in a multivalent format. Foreign peptides displayed on VLPs exhibit the same high immunogenicity as unmodified VLPs. Even self-antigens, normally subject to the mechanisms of B cell tolerance, are immunogenic when displayed at high density on the surface of VLPs. Several VLP-based vaccines that target heterologous foreign antigens derived from pathogens and self-antigens involved in disease are currently in clinical trials. As a powerful tool for vaccine development and discovery, we have applied

Funding: Latvian Council of Science Colaboration project # 10.0029. Innovative approaches for the investigation of molecular genetic properties of microorganisms and mechanisms of related systemic damage, and for the development of individualised monitoring, diagnosis and therapy of infectious diseases. Period: 2010-2014. Subproject manager: Dr. habil. biol. Pauls Pumpēns. Molecularly-epidemiologic background will be created for development of new vaccination strategy- individualized therapeutic vaccines (ITV). For ITV development, information about B, T and CTL epitopes of HBV and HCV variants of patients from Latvian Infectology Centre (LIC). For this purpose HBV (preS+S, C, P, X) and HCV (core, E1, E2, NS3, NS5) genome regions will be sequenced. HBV core-antigen (HBc) will be used as a virus like particle (VLP) platform for ITV development. For the most suitable VLP vector selection, HBc genes from LIC patients will be cloned and expressed in E.coli. HBc genes from LIC patients will ...

3. HPV blokuje produkcj? interferonu, przez co zabezpiecza w?asn? replikacj?. Odbywa si? to drodze produkcji dwóch bia?ek wczesnych E6 i E7, które wi??? i inaktywuj? wolne rodniki generowane podczas produkcji interferonu. Wykazano, ?e g?ówne bia?ko kapsydu - bia?ko L1 odgrywa istotn? rol? w odpowiedzi immunologicznej. Na modelu zwierz?cym stwierdzono, ?e u zwierz?t immunizowanych bia?kiem L1 (papillomavirus L1 virus like particles, VLPs) dochodzi do produkcji neutralizuj?cych przeciwcia? i ca?kowitej ochrony immunizowanego zwierz?cia przez zaka?eniem HPV. Przeprowadzono dwa du?e badania dotycz?ce zastosowania szczepionki wyprodukowanej z VLPs, których wyniki przedstawiono poni?ej ...

reative Biostructure can provide customized Mempro™ C1 domain-containing protein production services using virus-like particles system.

Hi, Im Victor Virus! But the grown-ups call me AAV. AAV is short for an Adeno Associated Virus - what a mouthful!. Viruses like me make people scared, they think were all bad. But I can be very useful. Its all thanks to my friends the scientists. Theyre very clever! They can use viruses like me to help sick people get better.. A gene is a very small part of the body - but its very important! It tells your body how to grow, and how it is supposed to work.. I can deliver hope for some sick people so I guess I really am a DNA superhero!. ...

Scientists report their phage-based inhaled vaccine delivery system elicited a robust antibody response in both mice and non-human primates.

When a virus like influenza enters our lungs, it is quickly faced with cocktails of molecules that recognize it and alert the host of its presence. Signals

Aims To analyse the effects of hyperglycaemia and blood pressure, diabetes and anti-hypertension treatment on total and various types of cardiovascular disease incidence in patients with Type 2 diabetes followed for 30years. Methods A total of 740 incident patients with Type 2 diabetes were registered at the Laxa Primary Health Care Centre, Sweden between 1972 and 2001. Information on systolic, diastolic, and mean arterial blood pressure, mean fasting blood glucose, type of diabetes and anti-hypertension treatment was obtained from the patient records, and information on cardiovascular disease, myocardial infarction and stroke events from National Registers. Results During the follow-up period the cumulative incidence of cardiovascular disease increased significantly with male sex (HR 1.52, 95% CI 1.251.85), age (HR 1.05, 95% CI 1.041.07), year of diabetes onset (HR 1.03, 95% CI 1.011.05), BMI, (HR 1.04, 95% CI 1.021.07), mean arterial blood pressure (HR 1.04, 95% CI 1.021.05) and number of ...

Novavax, Inc., has announced that patient enrollment has begun in its Phase 2 clinical trial of its new recombinant quadrivalent seasonal influenza virus-like particle vaccine, entitled Seasonal Influenza VLP.

Influenza virus-like particle vaccines produced in insect and plant cells, rapid sharing of influenza research, cytomegalovirus, viral evolution and symbiosis.

Case Study. Viruses are comprised of several structural proteins which make up the outer shell of the virus particle. Genetic material (either RNA or DNA) is contained within the core of these virus particles. When virus particles are produced without genetic material in their core they are unable to replicate and are referred to as virus like particles (VLP). These VLPs still retain the ability to elicit an immune response as they maintain the critical structural proteins and have been shown to be of use in biomedical applications. VLPs have, for example been used as vaccines (such as Engerix®, for hepatitis B virus and Cervarix®, for papillomavirus), and have several advantages over conventional attenuated viral vaccines since there is no risk of them becoming infectious genetic material.. The development and modification of the plant derived virus Cowpea mosaic virus (CPMV) has provided a simple and effective route into the use of VLPs in medical applications. CPMV derived VLPs offer ...

Virus-like particles (VLPs) provide a well-established vaccine platform; however, the immunogenic properties acquired by VLP structure remain poorly understood. In this study, we showed that systemic vaccination with norovirus VLP recalls human IgA responses at higher magnitudes than IgG responses under a humanized mouse model that was established by introducing human PBMCs in severely immunodeficient mice. The recall responses elicited by VLP vaccines depended on VLP structure and the disruption of VLP attenuated recall responses, with a more profound reduction being observed in IgA responses. The IgA-focusing property was also conserved in a murine norovirus-primed model under which murine IgA responses were recalled in a manner dependent on VLP structure. Importantly, the VLP-driven IgA response preferentially targeted virus-neutralizing epitopes located in the receptor-binding domain. Consequently, VLP-driven IgA responses were qualitatively superior to IgG responses in terms of the ...

Novavax is developing vaccines based on virus-like particle (VLP) technology developed at the University of Massachusetts Medical School (UMMS) in Worcester.

Hypertension primary or secondary does affect vital body organs and prove fatal at large. Anti-hypertension pills do have damaging effects due to their prolong use. DIASYSTOS is a marvelous non-medicinal alternative anti-hypertension sprays & drops that not only reduce blood pressure down to normal rapidly but also improves nerve signal tones and regulate blood chemistry. Continuous use of DIASYSTOS for 2-3 months will almost eliminate hypertension pills along with their side-effects. DIASYSTOS reduces both systolic and diastolic pressure and is beneficial to most of hypertensive patients. It helps improving heart, liver & kidney function as well. It is therefore exclusively useful for diabetic patients too. Live healthier and long life with DIASYSTOS…... ...

Testing innovative approaches to vaccine delivery This project will test two innovative approaches for vaccine delivery - one gender accommodative and one gender transformative - by adapting CAREs Gender Transformative Farmer Field and Business School approach to facilitating womens sustained invo

Creative Biostructure now can provide custom Mempro™ Acyl CoA binding protein (ACBP) production service based on virus-like particles.

Pettit, Marie, Dyer, Paul D.R., Mitchell, John C., Griffiths, Peter C., Alexander, Bruce, Cattoz, Beatrice, Heenan, Richard K., King, Stephen M., Schweins, Ralf, Pullen, Frank, Wicks, Stephen R. and Richardson, Simon C.W. (2014) Construction and physiochemical characterisation of a multi-composite, potential oral vaccine delivery system (VDS). International Journal of Pharmaceutics, 468 (1-2). pp. 264-271. ISSN 0378-5173 (doi:10.1016/j.ijpharm.2014.03.046) Pettit, Marie, Dyer, Paul D.R., Mitchell, John C., Griffiths, Peter C., Alexander, Bruce, Cattoz, Beatrice, Heenan, Richard K., King, Stephen M., Schweins, Ralf, Pullen, Frank, Wicks, Stephen R. and Richardson, Simon C.W. (2014) Construction and physiochemical characterisation of a multi-composite, potential oral vaccine delivery system (VDS). International Journal of Pharmaceutics, 468 (1-2). pp. 264-271. ISSN 0378-5173 (doi:10.1016/j.ijpharm.2014.03.046) ...

Question - Noticed white floating skin like particles in urine, have bladder emptying problem. Cause?. Ask a Doctor about diagnosis, treatment and medication for Urinary tract infection, Ask an Internal Medicine Specialist

Question - White dust like particles floating in urine, took medication for a previous UTI. What could this be ?. Ask a Doctor about diagnosis, treatment and medication for Bacteriuria, Ask a Urologist

The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world.

CDC Split Type: WAES0703USA00294. Write-up: Information has been received from a physician concerning a patient who was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast). One day post vaccination with HPV rL1 6 11 16 18 VLP vaccine (yeast, the patient developed facial palsy (not further specified). The patient outcome was not reported. Additional information is not expected.. ...

Enveloped virus-like particles (VLPs) are increasingly used as vaccines and immunotherapeutics. Frequently, very time consuming density gradient centrifugation

There seems to be a recurring phenomenon in the technology press, where any trojan that affects Linux or Macs becomes front page news. On the other hand, trojans that affect Windows are mostly ignored, perhaps because this is considered to be the normal state of affairs. There are two common...

Antibiotics are strong medicines. Keep them that way. Prevent antibiotic resistance.. Antibiotics dont fight viruses - they fight bacteria. Using antibiotics for viruses can put you at risk of getting a bacterial infection that is resistant to antibiotic treatment. Talk to your doctor or other healthcare provider about antibiotics, visit www.cdc.gov/getsmart, or call 800-CDC-INFO (800-232-4636) to learn more.. Taking antibiotics for viral infections such as a cold, a cough, or the flu will NOT:. ...

If this is your first visit, be sure to check out the FAQ by clicking the link above. You must have to REGISTER before you can post: Click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below.. ...

Buy Norvasc Online! Norvasc is an effective strong preparation which is taken in treatment of angina and hypertension diseases. Norvasc acts as an anti-angina and anti-hypertension remedy. Norvasc operates by reducing blood pressure and regulating chest pain through blood provision to the heart.

Product Name: S-amlodipine CAS NO.: 103129-82-4Usage: Anti-hypertension Molecular formula: C20H25N2O5Cl C6H6O3S Molecular weight: 567.05 Appearance:white

We use cookies to ensure that we give you the best experience on our website. If you click Continue well assume that you are happy to receive all cookies and you wont see this message again. Click Find out more for information on how to change your cookie settings ...

Researchers at the McGill University have devised a method that will boost the natural defence mechanism of an organism that will make the cells immune to viruses like influenza.

Several infections are caused by different kinds of viruses. Test your knowledge on infections caused by viruses like influenza, smallpox, polio and HIV.

Extractions of cells expressing VLP54, VLP6 (a GFP fusion to the ER protein HO-2), and LBR-S (a GFP fusion to a truncated LBR). BHK cells were transiently trans

This is a very good question. Certainly life would have remained at a very primitive level without the ability of genetic material to mutate. The balance is primarily mantained by the accuracy of polymerases that copy DNA and by the efficiency of error correcting mechanisms. The environment also plays a role in creating errors in non-replicating DNA that can be copied later, though this is pretty much a non-changing parameter ...

Block SL, Nolan T, Sattler C, et al; Protocol 016 Study Group. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics. 2006; 118: 2135-2145 ...

The polypeptide composition of HIV-I virus-like particles produced by CV-I cells during mono- and coinfection with recombinant vaccinia virus (rVV) strains containing the whole (p55) and carboxyterminal truncated (p48) gag genes and gag-pol sequence is studied. In monoinfection both the gag-strains actively produced virus-like particles consisting of non-processed p55Gag and p48Gag polyprotein without p6 domain. In case of a coinfection of the cells with one of these strains and the rVV producing p160Gag-Pol polyprotein the virus-like particles consisted of p24 protein and a negligible amount of non-processed Gag precursors. The share of p24 protein increased in proportion to the duration of coinfection and decreased with a reduction of multiplicity of infection with rVV carrying p160Gag-Pol. Hence, the absence of p6 domain does not influence the processing of Gag proteins during virus-like particles assembly and budding. In contrast to the natural systems of HIV-I development, in the rVV expression

Mesothelin is found in other cancers for several years, said Yao, also a researcher in the Dan L. Duncan Cancer Center at BCM. However, we didnt know the role it played in pancreatic cancer: until she and her colleagues reported in this article. In fact, they found very high levels of mesothelin in 18 of 21 samples of patients pancreatic tissues compared to amounts found in nearby normal tissues. In studies of this protein in the lab, pancreatic cancer cell lines that produced high levels of mesothelin grew faster and spread more than those in which mesothelin levels were lower. Pancreatic cancer cells grew and spread faster in mice whose tumors expressed high levels of mesothelin than in those whose cancer did not, said the researchers, who conducted the studies in an immune deficient mouse. ...

Immunization with Human Papillomavirus (HPV) L1 virus‐like particles or L2 capsid protein elicits neutralizing antibodies that mediate protection

Article Characterization of recombinant norovirus virus-like particles and evaluation of their applicability to the investigation of norovirus removal performance in membrane filtration processes. Noroviruses (NVs) are one of the leading causes of ep...

17.10.20 Computational study of folding and assembly of virus-like particles, KIT, Karlsruhe, Germany , Computational Chemistry List, Resource for Computational Chemists, molecular modeling, and associated archives

This study will examine the safety and tolerability of octavalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) vaccine formulated with amorph

The white blood cells act as an army of fighting cells, protecting your body from bad cells known as germs. White blood cells can capture germs and even swallow them.

諾羅病毒（Norovirus ;NoV）是引起人類非細菌性急性腸胃炎的主要致病原。主要症狀為嘔吐及腹瀉，有時患者會引發嚴重的併發症狀像是脫水、抽搐甚至死亡。由於諾羅病毒目前尚未能在細胞株內繁殖培養，也無有致病症狀的動物模式可提供研究，所以開始使用重組蛋白系統表達出諾羅病毒的類病毒顆粒（Virus-like particle ;VLP），其具有保留原始病毒的抗原性且不帶有核酸所以不具有致病力的優點，因此成為研究諾羅病毒的重要工具。現今人類諾羅病毒分成兩個主要的基因群：GI和GII，且兩基因群又細分成許多的基因型。在全球群聚感染事件當中，諾羅病毒GII/4為主要引起流行的諾羅病毒基因型，而在台灣GII/4亦為最常由群聚感染檢體中檢測出的基因型。近期，根據台灣疾病管制局的長期監測發現，有兩株未經報導過的新型GII/4台灣本土突變病毒株出現。

The Postnova modular FFF platform can be configured for any single or combination of several of the five FFF subtechniques - Asymmetric Flow FFF (AF4), Hollow-Fibre Flow FFF (HF5), Electrical FFF (EAF4), Centrifugal FFF CF3) and Thermal FFF (TF3). Because of this flexibility, it can be used for the separation, characterization and fractionation of nearly any macromolecules or nanoparticles. The Postnova platform can be also configurated for Size Exclusion Chromatography (SEC or GPC). You can easily switch from FFF to SEC and vice versa. The NovaFFF software takes care of control, data acquisition and calculation. ...

Prolonged exposure to viruses like Corona actually benefits the capacity of the immune system to adapt. Were not meant to be hermetically sealed organisms, but that is ultimately where the medical establishment is leaving us. Due to incarceration and self-isolation policy we are rendered more susceptible to long-term infections, accelerated neuro-degeneration and prone to diseases we might otherwise skirt altogether. No matter how daunting the task may seem, the only way to build antibodies to Covid-19, for our bodies to learn and adapt to it, is through natural environmental exposure to the strain - regardless of the risk factor, albeit it is sensible to shelter those in the community with acutely fragile immunity and pre-existing medical conditions, often resulting from vaccine-injury and prescription drug-dependency. Epidemiologists and virologists are well aware of this knowledge, but have either been sworn to silence, and intimidated by medical authorities such as the AMA, on fear of being ...

Antivirals and Antiretrovirals are a class of medication specifically used to treat viral and retroviral infections caused by viruses like HIV, herpes viruses, hepatitis B and C. Antivirals are a class of drugs which are used to treat viral infections.

Im Christina Brayn. Im from US-Dallas. Im am so excited am a Complete woman Again, I Was Infected With Herpes virus since 3 Years now I am devastated and am finding it hard to cope i was emotionally down I Have Been Seriously Praying To God And Searching For Cure.So as I was browsing through the Internet one day, I came across a website that suggested that Dr. IyaryI can help cure any type of virus like Herpes, Hiv/Aids cancer and Asthma…e.t.c And I Contacted Him, He Sent Me A Medicine And Directed Me On How I Will Take The Medicine For 21 Days, I Did So And Went For A Test And My Result Came Out As Negative. I Am So Happy, I Shared Tears Of Happiness And I Have Taken It Upon My Self To Always Testify About How God Used Dr. IyaryI To Solve My Problem. I Am A Clean woman Now, Without Any Virus If You Are Infected With Any Disease Like HIV AIDS, CANCER ,HERPES Or Any Other Disease You Can Also Be Happy Like Me By Contacting Dr. Iyaryi Through His Email [email protected] And also Reach ...

We will first describe how forward physics can lead to a better insight on the proton structure in terms of quarks and gluons at the LHC in the high gluon density regime. We will also discuss how detecting protons at the LHC leads to unprecedented sensitivities to Axion Like Particles and quartic photon anomalous coupling increasing the usual sensitivities to couplings by more than three orders of magnitude at the LHC ...

Terianne M. Wong is the author of this article in the Journal of Visualized Experiments: Expression and Purification of Virus-like Particles for Vaccination